CH616959A5 - - Google Patents

Download PDF

Info

Publication number
CH616959A5
CH616959A5 CH1590874A CH1590874A CH616959A5 CH 616959 A5 CH616959 A5 CH 616959A5 CH 1590874 A CH1590874 A CH 1590874A CH 1590874 A CH1590874 A CH 1590874A CH 616959 A5 CH616959 A5 CH 616959A5
Authority
CH
Switzerland
Prior art keywords
strain
virus
culture
parent
attenuated
Prior art date
Application number
CH1590874A
Other languages
German (de)
English (en)
Inventor
Abraham Seftel Beare
David Arthur John Tyrrell
David Mccahon
Original Assignee
Wellcome Found
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Nat Res Dev filed Critical Wellcome Found
Publication of CH616959A5 publication Critical patent/CH616959A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CH1590874A 1973-11-29 1974-11-29 CH616959A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB55469/73A GB1488800A (en) 1973-11-29 1973-11-29 Influenza vaccines

Publications (1)

Publication Number Publication Date
CH616959A5 true CH616959A5 (xx) 1980-04-30

Family

ID=10474009

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1590874A CH616959A5 (xx) 1973-11-29 1974-11-29

Country Status (19)

Country Link
US (1) US3991179A (xx)
JP (1) JPS5094115A (xx)
AT (1) AT331980B (xx)
AU (1) AU498810B2 (xx)
BE (1) BE822736A (xx)
CA (1) CA1044138A (xx)
CH (1) CH616959A5 (xx)
CS (1) CS199569B2 (xx)
DE (1) DE2456636A1 (xx)
DK (1) DK139807B (xx)
ES (1) ES432385A1 (xx)
FR (1) FR2253535B1 (xx)
GB (1) GB1488800A (xx)
HU (1) HU173548B (xx)
IE (1) IE40221B1 (xx)
NL (1) NL7415614A (xx)
PL (1) PL97723B1 (xx)
SE (1) SE422154B (xx)
ZA (1) ZA747602B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6042209B2 (ja) * 1974-05-31 1985-09-20 北里研究所（社団法人） インフルエンザウイルスの新鮮分離株を発育鶏卵へ短期間で順化させる方法
US4318903A (en) * 1978-07-12 1982-03-09 Smithkline-Rit Live influenza virus vaccine and the preparation thereof
US4338296A (en) * 1979-10-16 1982-07-06 Smithkline-Rit Influenza virus and process of producing a vaccine therefrom
US4278662A (en) * 1979-10-16 1981-07-14 Smith Kline - Rit Attenuated influenza type A virus vaccine
US4554159A (en) * 1981-11-12 1985-11-19 Institute Merieux Vaccine and method of immunizing against herpes simplex virus (types 1 and 2)
US4743553A (en) * 1984-07-18 1988-05-10 W. R. Grace & Co. Synthetic genes for bovine parainfluenza virus
US4783411A (en) * 1984-10-22 1988-11-08 Janis Gabliks Influenza-A virus vaccine from fish cell cultures
AU2005242409A1 (en) * 2004-05-19 2005-11-24 Alza Corporation Method and formulation for transdermal delivery of immunologically active agents
US7468187B2 (en) 2005-10-18 2008-12-23 Iowa State University Research Foundation, Inc. Canine influenza virus and related compositions and methods of use

Also Published As

Publication number Publication date
AU498810B2 (en) 1979-03-29
IE40221B1 (en) 1979-04-11
SE422154B (sv) 1982-02-22
AT331980B (de) 1976-09-10
US3991179A (en) 1976-11-09
BE822736A (fr) 1975-05-28
AU7587674A (en) 1976-06-03
DK139807C (xx) 1979-09-24
SE7414918L (xx) 1975-05-30
JPS5094115A (xx) 1975-07-26
GB1488800A (en) 1977-10-12
FR2253535B1 (xx) 1978-07-21
CS199569B2 (en) 1980-07-31
PL97723B1 (pl) 1978-03-30
DK139807B (da) 1979-04-23
NL7415614A (nl) 1975-06-02
ES432385A1 (es) 1977-06-16
IE40221L (en) 1975-05-29
CA1044138A (en) 1978-12-12
DK618274A (xx) 1975-07-28
ZA747602B (en) 1976-07-28
FR2253535A1 (xx) 1975-07-04
HU173548B (hu) 1979-06-28
ATA953774A (de) 1975-12-15
DE2456636A1 (de) 1975-06-05

Similar Documents

Publication Publication Date Title
DE69732407T3 (de) Verfahren für die Replikation von Influenza in Zellkultur und die bei diesem Verfahren hergestellten Influenza-Viren
AT407958B (de) Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
DE19612966A1 (de) Tierische Zellen und Verfahren zur Vermehrung von Influenzaviren
DE2708668A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2713371C2 (xx)
CH617588A5 (xx)
DE2817891A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
CH616959A5 (xx)
DE2362067C2 (de) Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DE2323847C3 (de) Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion
DE69835424T2 (de) Boviner atmungs- und darmcoronavirus als impfstoff
DE2445819A1 (de) Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen
CH659084A5 (de) Artifiziell erzeugter tollwutvirus-stamm und verfahren zu seiner gewinnung.
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE1617545C2 (de) Verwendung von informatorischer Ribonucleinsäure als Vaccine
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
DE1176317B (de) Verfahren zur Herstellung von fuer Impf-zwecke geeigneten waessrigen Fluessigkeiten mit Tollwut-Virus
DE1235505B (de) Verfahren zur Herstellung einer Vaccine gegen Staupe
CH618091A5 (en) Method for the attenuation of virulent feline rhinotracheitis virus and use of this virus for the production of a vaccine
DE2415353A1 (de) Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen
DE3005495C2 (de) Herstellung von Fragmenten von Viren mit Lipidhülle und sie enthaltende Arzneimittelzubereitungen
CH638985A5 (de) Verfahren zur herstellung eines tollwutimpfstoffes und danach erhaltener impfstoff.
DE19655440B4 (de) Verfahren zur Herstellung eines Influenzaimpfstoffs
DE2126957B2 (de) Verfahren zur herstellung von impfstoffen gegen gaensehepatitis

Legal Events

Date Code Title Description
PL Patent ceased